Our DCD Event

Our DCD Event

This year, FEL Group attended the DCD (DataCenterDynamics) award programme that celebrated our industry’s best data centre solutions, projects and most talented people.

Our staff who attended was Ged, John, Michelle, Darren, Jonathan, Phil, Mark, Kathy, Mick, Huw, Jonathon and Charlotte.

We are proud to say that the overall event went exceptionally well, leaving us introduced to companies across the globe. Not only did we engage with other companies, we were a lead sponsor, attended 1-2-1 meetings, attended round table discussions, involved in speed networking and presented in front of over 80 people. We also held an exhibition stand over the two days which was constantly busy and full of potential clients.

Our presentation shared real lessons learned when using modular solutions to increase the capacity of existing data centres. This was evolved around the experience of a certain specialist modular case study, including what obstacles FEL Group faced and what actions were taken place to overcome these.

We would like to thank everyone who attend our presentation and who came and engaged with us at our stand. We loo forward to following up on our potential opportunities with new customers and suppliers.


Nigel Barber's Rally Experience...

I think it’s fair to say nobody overtook Nigel.. big smiles on exit and not a green face in site only the adrenaline rush smile.

Img 9739

DCD Event

Ged Doolan and his team will be presenting at 12:20pm on Monday 5th November at this year's #DCDLondon Event.

20181012 133423

Sarah's Graduation

Sarah, our HR Advisor, recently graduated from her course!

Img 8962

Nigel's 20 years of service...

Celebrating Nigel's 20 years of service with FEL Group.

Screen Shot 2018 11 20 At 09 20 59

Appointment of our new Business Dev...

In the month of October 2018, we appointed Jonathan as FEL Group's Business Development Director.

Macmillan 2

Macmillan Cancer Support

During October, the team at FEL Group held a Coffee Morning; this helped to raise money to support the funding towards research into discovering treatments for cancer.